Keywords: further, eu, approval, s-p, hcv, drug, combo
Further EU approval for S-P's HCV drug combo
Article | 26 November 2007
US drug major Schering-Plough says that the European Commission has approved 48-week standard-dose Pegintron (peginterferon alfa-2b, 1.5mcg/kg once-weekly) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
